CLASS II ONGOING Device recall · Reported 17 Sep 2025 · FDA Enforcement Report

Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP) recalled

Siemens Healthcare Diagnostics is recalling Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP), distributed nationwide in the US. The recall was initiated on 11 Aug 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMaterial Number: 11097543. Test Code: UCFP. UDI-DI: 00630414279206. All lot numbers.
Quantity recalled11,811 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2542-2025
FDA event ID
97398
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Ongoing
Recall initiated
11 Aug 2025
FDA classified
8 Sep 2025
Reported
17 Sep 2025
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

11 Aug 2025Recall initiated by company
8 Sep 2025Classified by FDA+28 days
17 Sep 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for falsely depressed patient, quality control (QC), and/or calibration results or delayed results.

Product as listed by the FDA

Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP). Material Number: 11097543.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Bahamas, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cura¿ao,¿St¿Eus, Czech¿Republic, Denmark, Egypt, Estonia, Ethiopia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Macedonia, Malaysia, Maldives, Mexico, Nepal, Netherlands, New Zealand, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Turkmenistan, U.A.E., United¿Kingdom, Uruguay, Vatikancity, Vietnam, Zaire.

Nationwide Georgia

Questions about this recall

Why was it recalled?

Potential for falsely depressed patient, quality control (QC), and/or calibration results or delayed results.

Which lots are affected?

Material Number: 11097543. Test Code: UCFP. UDI-DI: 00630414279206. All lot numbers.

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Austria, Bahamas, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cura¿ao,¿St¿Eus, Czech¿Republic, Denmark, Egypt, Estonia, Ethiopia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Macedonia, Malaysia, Maldives, Mexico, Nepal, Netherlands, New Zealand, Norway, Oman, Pakistan, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Turkmenistan, U.A.E., United¿Kingdom, Uruguay, Vatikancity, Vietnam, Zaire.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Spinal Implants recalls

All 1,157